Topical Steroid for Facial Eczema Around Eyes
For periorbital eczema, use hydrocortisone 1% ointment as first-line treatment, applied twice daily for short periods only, and strongly consider tacrolimus 0.03-0.1% ointment as a safer alternative for longer-term control to avoid the significant risk of ocular complications from corticosteroids.
Treatment Algorithm
First-Line Approach
Start with mild-potency topical corticosteroids for the periorbital area 1. The fundamental principle is using the least potent preparation required to control eczema 1. For facial and periorbital eczema specifically:
- Hydrocortisone 1% ointment is adequate for periorbital use 1
- Apply twice daily maximum 1
- Use for limited periods only due to the high-risk periorbital location 1
Critical caveat: Very potent and potent category steroids should be used with extreme caution and for limited periods only around the eyes 1. The main risk is suppression of the pituitary-adrenal axis, particularly concerning in children, plus local ocular complications including glaucoma and cataracts from periorbital absorption 1.
Steroid-Sparing Alternative (Preferred for Maintenance)
Tacrolimus ointment 0.1% (adults) or 0.03% (children) is strongly recommended for periorbital eczema 2, 3, 4, 5:
- Apply to eyelid margins twice daily 2, 4
- High-certainty evidence supports strong recommendation for tacrolimus in atopic dermatitis 3
- Superior safety profile: Does not cause increased intraocular pressure, unlike corticosteroids 4
- Effective for both acute flares and maintenance therapy 4, 5
- Can be used for 1-4 weeks or longer as needed 5
A 2007 double-masked crossover study comparing tacrolimus 0.1% to clobetasone butyrate 0.05% in atopic keratoconjunctivitis patients showed tacrolimus had near-superior benefit for eyelid eczema signs (P=0.05) with no effect on intraocular pressure 4. A 2024 case series confirmed safety and effectiveness in both adults and children with periorbital atopic dermatitis 5.
Practical Application Strategy
For Acute Flares
- Start with hydrocortisone 1% ointment twice daily
- Continue until signs improve (typically 1-2 weeks maximum)
- Transition to tacrolimus ointment for continued control
For Maintenance/Recurrent Disease
- Use tacrolimus ointment as first-line to avoid steroid complications 2, 3
- If tacrolimus ineffective after 2-4 weeks with appropriate application, consider short-term return to mild-potency corticosteroid 2
Adjunctive Measures (Essential)
- Emollients: Apply after bathing to provide surface lipid film 1
- Soap substitutes: Use dispersible cream instead of soap 1
- Avoid extremes of temperature 1
Key Warnings for Periorbital Use
Do NOT use moderate, potent, or very potent corticosteroids around the eyes except under specialist supervision for very limited periods. The 2024 dupilumab ocular surface disorder guidelines specifically recommend:
- Short-term ocular topical corticosteroids only (preservative-free dexamethasone 0.1%, prednisolone 0.5%, or hydrocortisone 0.335% eyedrops) for moderate-to-severe cases 2
- Early introduction of corticosteroid-sparing agents like tacrolimus or ciclosporin drops 2
- Avoid prolonged ocular corticosteroid therapy (>8 weeks) due to serious adverse effects risk 2
When to Refer
Consider ophthalmology referral if 2:
- Requiring topical corticosteroids >8 weeks
- Progressive loss of visual acuity
- Significant quality of life impact despite treatment
- Development of ocular complications
The evidence strongly favors tacrolimus as the safer long-term option for periorbital eczema, reserving mild-potency corticosteroids only for short-term acute management 2, 3, 4, 5.